Company issued its 2024 Annual Report to Shareholders and announced the date for its 2025 Annual General Meeting. The ...

Dyne Therapeutics’ DYNE-101 shows positive results in phase 1/2 ACHIEVE study. Read why DYN stock may rise with FDA approval and a $2.78B market opportunity.

We view SentinelOne as an emerging challenger in the endpoint security space, a prominent part of the cybersecurity stack that has been dominated by larger competitors such as Microsoft and ...

We expect Teradyne to maintain a strong balance sheet and continue generating robust free cash flow while keeping minimal to no leverage. As of Dec. 31, 2024, Teradyne held a net cash position, with ...

As part of East Coast Group, a leading diversified conglomerate in Bangladesh, EC Organic Products Limited (ECOPL) continues to expand its portfolio with high-quality food essentials.

Ceragon Networks Ltd. CRNT has announced the launch of its latest innovative products — IP-100E ... Ceragon continues to expand its portfolio, reinforcing its core business while enhancing ...

Tencent (TCEHY) (HK:0700) has recently restructured its AI product portfolio, consolidating several teams and products under its Cloud and Smart Industries Group (CSIG). These changes reflect the ...

The oncology company is rapidly evolving its product portfolio to target a growing range of tumor types. Some of its key products include CABOMETYX, a drug for advanced renal cell carcinoma (RCC ...

Apollo Tyres, one of India’s largest tyre manufacturers, will refocus its product strategy to enhance profitability amid slower growth, rising input costs, and increasing competition.

Grok was quick to assess the macroeconomic conditions prevailing this year and conclude that an ideal portfolio would seek to balance strong growth and the principles of value investing while not ...

Fidelity Investments is the latest asset manager to ramp up its model-portfolio business as demand ... which allows the portfolios to hold products apart from their own.